FibroGen Inc. (FGEN), a biopharmaceutical company focused on accelerating the development of novel therapies at the frontiers of cancer, has significant catalysts to watch in the upcoming months.
The company's lead drug candidate is Pamrevlumab, which is in clinical development for the treatment of metastatic pancreatic cancer and locally advanced unresectable pancreatic cancer.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.